Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

XCUR

Exicure (XCUR)

Exicure Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:XCUR
DateTimeSourceHeadlineSymbolCompany
12/06/202407:18Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:XCURExicure Inc
12/06/202402:12Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:XCURExicure Inc
07/06/202406:23Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:XCURExicure Inc
07/06/202406:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
07/06/202406:17Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:XCURExicure Inc
07/06/202406:16Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:XCURExicure Inc
07/06/202406:01Business WireExicure, Inc. Reports Full Year 2023 Financial ResultsNASDAQ:XCURExicure Inc
24/05/202406:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
24/05/202406:01Business WireExicure, Inc. Received Nasdaq Notice of a Delisting DeterminationNASDAQ:XCURExicure Inc
24/05/202402:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XCURExicure Inc
17/05/202406:59Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XCURExicure Inc
17/05/202406:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
17/05/202406:45Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:XCURExicure Inc
17/05/202406:40Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:XCURExicure Inc
17/05/202406:08Business WireExicure, Inc. Reports Third Quarter 2023 Financial ResultsNASDAQ:XCURExicure Inc
16/05/202406:45Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:XCURExicure Inc
23/04/202406:01Business WireExicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-KNASDAQ:XCURExicure Inc
07/03/202404:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XCURExicure Inc
05/03/202410:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XCURExicure Inc
05/03/202409:37Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:XCURExicure Inc
06/02/202408:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
06/02/202408:01Business WireExicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of HepatitisNASDAQ:XCURExicure Inc
17/01/202408:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
02/12/202310:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XCURExicure Inc
02/12/202308:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
29/11/202308:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
29/11/202308:01Business WireExicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-QNASDAQ:XCURExicure Inc
15/11/202308:28Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:XCURExicure Inc
07/10/202308:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XCURExicure Inc
30/09/202307:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:XCURExicure Inc
 Showing the most relevant articles for your search:NASDAQ:XCUR